Optimizing Treatment of Metastatic Colorectal Cancer

Hollywood, FL US
March 14, 2014

Target Audience

This educational activity is designed to meet the needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.

Learning Objectives

Following this program, participants should be able to:

  • Select optimal first-line treatment for patients with newly diagnosed metastatic colorectal cancer based on individual patient and tumor characteristics and the extent of disease to improve patient outcomes
  • Determine optimal treatment strategies to improve clinical outcomes for patients with metastatic colorectal cancer who progress on first-line therapy
  • Manage toxicities related to therapeutic agents used for patients with metastatic colorectal cancer
Additional information
Supporters: 

Supported by educational grants from Bayer HealthCare Pharmaceuticals Inc.; Genentech; and Lilly.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
03/14/2014
Course expires: 
08/31/2016
Event starts: 
03/14/2014 - 7:00am
Event ends: 
03/14/2014 - 8:00am
Cost:
$0.00
The Westin Diplomat
3555 South Ocean Drive
Hollywood, FL 33019
United States

Tanios Bekaii-Saab, MD
The Ohio State University Comprehensive Cancer Center -
James Cancer Hospital and Solove Research Institute

Alan P. Venook, MD
UCSF Helen Diller Family Comprehensive Cancer Center

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Accreditation Period

Course opens: 
03/14/2014
Course expires: 
08/31/2016

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Reader or other PDF reader software for certificate viewing/printing